Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27041-27050 Newer>

The Motley Fool November 2, 2007 Timothy M. Otte	Dairy Costs Dump on Kraft Kraft's quarterly report boasts top-line momentum, but unfortunately, it didn't trickle down to the bottom line.
The Motley Fool November 2, 2007 Rick Aristotle Munarriz	6 Retail Stocks Under $10 These stocks are so cheap, you might even say they're on sale: Denny's... Leap Frog Enterprises... Pier 1 Imports... Back Yard Burgers... Haverty... Tuesday Morning...
CFO November 1, 2007 Edward Teach	Working Capital: Fourth and Goal To buff up their fourth-quarter numbers, companies often play games with working capital. Unfortunately, the shine doesn't last.
Financial Planning November 1, 2007 Gene Fama	Small-World Investing Do international stocks really give you higher returns with less risk?
The Motley Fool November 1, 2007 Ron Vlieger	Weyerhaeuser Sees Money Growing on Trees The housing slump has hurt sales in the third quarter for the lumber and homebuilding company, but tax relief and a possible restructuring hold promise.
The Motley Fool November 1, 2007 Rich Smith	American Superconductor Gets Shocked American Superconductor beat analysts sales estimates this quarter, but still seems incapable of earning a profit.
The Motley Fool November 1, 2007 Rich Smith	It's Bad When Sales Decline, Right? Furniture Brands, the company behind Broyhill, Lane, and Thomasville, reported yet another quarter of declining sales.
The Motley Fool November 1, 2007 Brian Orelli	Good News From Amylin Isn't Good Enough Investors aren't impressed by Amylin's extended-release version of Byetta, worrying that the drug may be reaching market saturation.
The Motley Fool November 1, 2007 Matt Koppenheffer	UBS Strikes Up a Familiar Band Overall, UBS finished the quarter with a loss of $624 million, due in great part to the $3.6 billion in losses it reported in its fixed income currencies and commodities trading business.
The Motley Fool November 1, 2007 Brian Orelli	More Extrinsic Growth From Inverness on the Way Comparing year-over-year gains at Inverness Medical Innovations is becoming harder with each passing press release announcing the purchase of another company.
<Older 27041-27050 Newer> Return to current articles.